Health insurance giant UnitedHealth (NYSE: UNH) will be announcing its second-quarter financial results Thursday before the opening bell. While the robust subscriber
Categories
Other Industries
Abbott exceeds Q2 earnings estimates; raises 2019 outlook
Abbott Laboratories' (NYSE: ABT) second quarter earnings topped estimates, while revenue came in line with the expectations. The company also lifted its
Will cigarettes hurt Philip Morris Q2 earnings results?
Philip Morris International (NYSE: PM) is scheduled to report its earnings results for the second quarter of 2019 on Thursday before the
Earnings: Cintas Q4 results top Street view; stock jumps
Corporate uniform marker Cintas (Nasdaq: CTAS) reported strong revenue and earnings growth for the fourth quarter. The results also surpassed the estimates
What to look for when Chewy reports Q1 earnings results?
Online pet supplies retailer Chewy (NYSE: CHWY) is scheduled to report its maiden earnings results for the first quarter of 2019 on
Q2 results will help investors merit Novartis’ strategic transformation
Novartis AG (NYSE: NVS) is scheduled to report second-quarter earnings before the opening bell on Thursday, July 18. The Switzerland-based pharmaceutical giant
Earnings preview: Abbott banks on medical devices for Q2 growth
Abbott Laboratories (NYSE: ABT) is set to release its earnings results for the second quarter of 2019 on Wednesday before the market
Earnings preview: Aluminum trends to hurt Alcoa Q2 2019 results
Alcoa Corporation (NYSE: AA) is scheduled to report its earnings results for the second quarter of 2019 on Wednesday after the market
Major marijuana stocks experience downward pressure this week
There has been extreme volatility in the share prices of Canadian-based cannabis companies’ stocks from their day one after getting listed on
Earnings preview: There is optimism for Johnson & Johnson in Q2 2019 despite setbacks
Johnson & Johnson (NYSE: JNJ) is scheduled to report second-quarter 2019 earnings results on Tuesday, July 16, before market open. Analysts have
What next for healthcare stocks after govt decision on drug rebate spurs rally?
The market reacted quickly to President Trump’s decision to withdraw the plan to do away with rebates in the government's drug plans.
Earnings preview: What to expect from ShiftPixy Q3 2019 results
For the third quarter of 2019, ShiftPixy's (NASDAQ: PIXY) top line will be benefited by the 19 new clients already onboard since
Fastenal Q2 profit declines 3%, misses estimates
Fastenal Company (NASDAQ: FAST) reported a 3% decline in earnings for the second quarter of fiscal 2019 due to the impacts of
Huya’s rival DouYu plans to raise about $950 million through IPO
Chinese e-sports giant DouYu International Holdings has set a price range of $11.50 to $14 per share for its US listing and
PriceSmart Q3 profit dips 25% but meets estimates
PriceSmart Inc. (NASDAQ: PSMT) reported a 25% dip in earnings due to higher costs and expenses despite higher revenue. The bottom line
Mylan under pressure as shortage of anti-allergy injector persists
Pharmaceutical company Mylan (Nasdaq: MYL), which has been facing criticism for the short supply of its anti-allergy injector EpiPen, suffered a jolt
Virgin Galactic vs. Blue Origin: The race to suborbital space tourism
Written by Arjun Vijay On Tuesday, Virgin Galactic announced that it was going public, setting a new milestone for the space tourism
AngioDynamics posts in-line EPS of $0.25 in Q4
AngioDynamics (NASDAQ: ANGO) posted fourth-quarter earnings results on Wednesday before the regular trading hours. Net sales for the period increased 9% to $96.3
Levi Strauss stock falls after Q2 earnings drop on IPO costs, miss estimates
Denim specialist Levi Strauss (NYSE: LEVI), which returned to the public market two months ago, reported weaker than expected earnings for the
Cronos Group ropes in Mondelez executive to drive innovation in product development
Global cannabinoid firm, Cronos Group (NASDAQ: CRON) on Tuesday announced the appointment of Dr. Todd Abraham as its Chief Innovation Officer. He
Lindsay Q3 profit dips 72%, misses estimates
Lindsay Corporation (NYSE: LNN) reported a 72% dip in earnings for the third quarter of fiscal 2019 due to lower revenues, lower